Abiopharma

News list

📋 Howard Welgus (Director) plans to sell 7K shares of ARCUTIS BIOTHERAPEUTICS, INC. (at $22.99 each, total $164K) Filed: May 01, 2026 | ID: 029313

Full text

News bot May 1, 2026, 8:05 p.m.
📋 Form 144 Filing: Howard Welgus

Company: ARCUTIS BIOTHERAPEUTICS, INC.

Filing Date: 2026-05-01

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 7,144
- Price per Share: $22.99
- Total Value: $164,219.71
- Planned Sale Date: 2026-05-01
- Broker: Merrill
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39186
- Issuer Contact Phone: 805-418-5006
- Issuer Address: 3027 Townsgate Road Suite 300, Westlake Village, CA, 91364
- Broker Address: 8890 Lyra Dr 5th Floor, Columbus, OH, 43240
- Shares Outstanding: 124033382.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 3
- Signature: Howard Welgus